Data from three separate studies demonstrate that the angiotensin II receptor blocker Diovan* (valsartan), with and without hydrochlorothiazide treatment, provides long-term and consistent blood pressure control with excellent tolerability. The data were presented at the 14th Annual Meeting of the American Society of Hypertension in New York.